Blackstone Life Sciences
Private equityCambridge · Series A–Late Stage · 8 people tracked
✨ Fox Verdict
Sign up to see your fitStage
Series A–Late Stage
Check
$20M – $60M
HQ
Cambridge, US
Instruments
Equity
Founded
2005
AUM
$12B
Team · 8 people
from the firm's websiteAri Brettman· Senior Managing Director
Barry Gertz· Managing Director
Colm Foley· Managing Director
Kiran Reddy· Senior Managing Director
M. Craig Shepherd· Senior Managing Director
Paris Panayiotopoulos· Senior Managing Director
Robert Liptak· Senior Managing Director
Nicholas Galakatos· Global Head of Life Sciences
Frequently asked questions
- What stage does Blackstone Life Sciences invest at?
- Blackstone Life Sciences invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What is Blackstone Life Sciences's typical check size?
- Blackstone Life Sciences typically writes checks of $20M – $60M.
- What sectors does Blackstone Life Sciences focus on?
- Blackstone Life Sciences focuses on Crypto & Web3, Sector Agnostic.
- Where is Blackstone Life Sciences located?
- Blackstone Life Sciences is headquartered in Cambridge, US.
Featured in lists
Series A Investors & VC FirmsCrypto & Web3 Investors & VC FirmsInvestors & VC Firms in United StatesSeries B Investors & VC FirmsLate Stage Investors & VC FirmsSeries A Investors & VC Firms in United StatesGrowth Investors & VC FirmsSeries C Investors & VC FirmsSeries B Investors & VC Firms in United StatesInvestors & VC Firms in EuropeSeries A Investors & VC Firms in EuropeLate Stage Investors & VC Firms in United States